Description

In this week’s episode, we focus on Intermountain Healthcare’s announcement that it has formed a “comprehensive health platform company focused on elevating value-based care capabilities.” The new organization, named Castell, will be led by Rajesh Shrestha as president and CEO. Shrestha will continue to serve as vice president and chief operating officer of Community Based Care for Intermountain.

Other briefs include:

• Gilead Sciences’ research and development collaboration with Belgian biopharmaceutical company Galapagos NV, valued at more than $5 billion.
• Genentech’s recent spate of research agreements.
• John Muir Health is forming “a comprehensive relationship” with Optum.
• The closing of Michigan’s Together Health Network.
• Physician participation in CMS’ Advanced Alternative Payment Models doubles in 2018.
• Care New England withdraws from merger discussions with Lifespan and Brown University.
• Memorial Hermann names Dr. David Callender as its new president and CEO, effective September 1.

About Darwin Research Group

Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.

 CONNECT WITH US:

🌐 Visit us on the web

 🌐 Follow Health Care Rounds on LinkedIn

 🌐 Follow Darwin Research Group on LinkedIn

📺 Watch Health Care Rounds on YouTube

🎧 Listen on Apple Podcasts

🎧 Listen on Spotify

⚙️ Health Care Rounds is produced by Grippi Media